All news from Anaesthesiology

Being Aware of Memory Loss Lessens the Risk of Dementia

In a study published today in the Journal of Clinical Psychiatry, based on patients' awareness of their memory problems, researchers have identified a useful method to predict who won't develop Alzheimer's disease. People who were not aware of their memory loss, a condition called anosognosia, were more likely to progress to Alzheimer's disease and those who were aware of memory problems were unlikely to develop dementia.

SPARTAN device improves IVS success

The microfluidic device, which can be used in clinics, is dubbed SPARTAN, short for Simple Periodic ARray for Trapping And IsolatioN. It uses a field of three-dimensional posts that create an obstacle course for the swimming sperm cells. The strongest and healthiest sperm get through this array the fastest and then are collected at the outlet to be used in the in vitro fertilization (IVF) process.

Cognitive Therapy Is Effective In Reducing Severe Tinnitus

Authors examined the mindfulness-based cognitive therapy could offer an real new therapy for tinnitus. This single-site randomized controlled trial compared mindfulness-based cognitive treatment to intensive relaxation training (RT) for chronic, distressing tinnitus in adults. Tinnitus is experienced by up to 15% of the population and can lead to significant disability and distress. There is rarely a medical or surgical target and psychological therapies are recommended. This has published in the current issue of Psychotherapy and Psychosomatics.

Stroke Has Been Increased by Following Cardiac Procedures

According to this study, Stroke is a known problem of cardiac surgery, but there are few data related to stroke risk in the middle risk period from discharge up to one year of follow-up.  Apart from left atrial appendage (LAA) closure and ablation, ischemic stroke readmission rates following cardiac procedures were consistently higher than the highest-risk noncardiac surgery. This study has published in Journal of the American Heart Association.

Better Clinical Outcome For Aged; After Immunotherapy For Metastatic Melanoma

According to a small retrospective study from France has shown that the patients after immunotherapy treatment for metastatic melanoma. People over age of 65 will show equivalent, and perhaps better, clinical outcome than their younger counterparts. They examined whether the age of patients with metastatic melanoma affected response and tolerance to immunotherapy in a real-world clinical setting. This study has been published in JAMA Dermatology.